STSI running today. Earnings on Nov. 9. They have

STSI running today. Earnings on Nov. 9. They have a settlement of their lawsuit against Reynolds. We know that they got 5 million bucks but it is in a confidentiality agreement. If there is also a royalty plan for the future, this could really go. Their main product now is a systemic anti-inflammatory, available over the counter, but being tested in 9 different human trials at Johns Hopkins, and also several trials at the Roskamp Institute in Florida. It has had positive results in reducing inflammation in patients with auto-immune thyroiditis, and also has had positive results in head injury studies. It seems to lower the C-Reactive Protein (CRP) levels in diabetics. CRP is a market of heart disease so this has big implications.

It is a gamble because of the possibility that the Reynolds settlement will be disappointing, or that details will not be forthcoming because of the confidentiality agreement. I'd suggest using options, May or later calls, for anyone who wants to start a speculative position.

I will say that I've been taking their product, Anatabloc, for about 6 months now and it definitely is effective. Half a dozen of my friends have also started taking it and all have reported good results.